Hospital Profile
| Name | Mesa View Regional Hospital |
|---|
| Type | Critical Access Hospital |
|---|
| Location | 1299 Bertha Howe Avenue, Mesquite, Nevada |
|---|
| Ownership | Proprietary |
|---|
| Emergency Services | Yes |
|---|
| Medicare ID (CCN) | 291307 |
|---|
Patients' Experience Survey:
Overall Rating of the Hospital:
Willingness to Recommend Hospital:
Patients who reported YES, they would definitely recommend the hospital
Probably Patients who reported YES, they would probably recommend the hospital
No Patients who reported NO, they would probably not or definitely not recommend the hospital
Cleanliness of Hospital Environment:
Patients who reported that their room and bathroom were "Always" clean
Usually Patients who reported that their room and bathroom were "Usually" clean
Sometimes or Never Patients who reported that their room and bathroom were "Sometimes" or "Never" clean
Quietness of Hospital Environment:
Patients who reported that the area around their room was "Always" quiet at night
Usually Patients who reported that the area around their room was "Usually" quiet at night
Sometimes or Never Patients who reported that the area around their room was "Sometimes" or "Never" quiet at night
Always Patients who reported that their nurses "Always" communicated well
Usually Patients who reported that their nurses "Usually" communicated well
Sometimes or Never Patients who reported that their nurses "Sometimes" or "Never" communicated well
Always Patients who reported that their doctors "Always" communicated well
Usually Patients who reported that their doctors "Usually" communicated well
Sometimes or Never Patients who reported that their doctors "Sometimes" or "Never" communicated well
Responsiveness of Hospital Staff:
Patients who reported that they "Always" received help as soon as they wanted
Usually Patients who reported that they "Usually" received help as soon as they wanted
Sometimes or Never Patients who reported that they "Sometimes" or "Never" received help as soon as they wanted
Communication about Medicines:
Patients who reported that staff "Always" explained about medicines before giving it to them
Usually Patients who reported that staff "Usually" explained about medicines before giving it to them
Sometimes or Never Patients who reported that staff "Sometimes" or "Never" explained about medicines before giving it to them
Yes Patients who reported that YES, they were given information about what to do during their recovery at home
No Patients who reported that NO, they were not given information about what to do during their recovery at home
Always Patients who "Strongly Agree" they understood their care when they left the hospital
Usually Patients who “Agree” they understood their care when they left the hospital
Sometimes or Never Patients who “Disagree” or “Strongly Disagree” they understood their care when they left the hospital
NPI Associated with the Hospital:
Unlike individual providers, Hospitals may have multiple NPI numbers for example, there can be a separate NPI for each unit within the hospital. We have found possible NPI number/s associated with Mesa View Regional Hospital from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.
Structural Quality Measures:
| Able to receive lab results electronically | No |
| Able to track patients' lab results, tests, and referrals electronically between visits | No |
News Archive
Antigenics awarded $424,720 grant under QTDP program
Antigenics Inc. today announced that it has been awarded $424,720 in grants under the IRS' Qualifying Therapeutic Discovery Project (QTDP) program. The grants were awarded in recognition of our two qualifying programs: AG-707, a phase 1 therapeutic vaccine for the treatment of genital herpes and QS-21 Stimulon® adjuvant.
Importance of relative measures in policy on health inequalities
The British public supports the use of personal medical data, without consent, for public health research, finds a study published on bmj.com. Most people also think that cancer registration should be required by law.
Research provides new insight into the carefully controlled architectural changes that underlie organ development
A new research study demonstrates that a single chemical growth factor orchestrates a complex developmental process by sequentially activating distinct subsets of molecular signals.
FDA grants approval to first biosimilar for treatment of patients with breast, stomach cancers
The U.S. Food and Drug Administration today approved Ogivri (trastuzumab-dkst) as a biosimilar to Herceptin (trastuzumab) for the treatment of patients with breast or metastatic stomach cancer (gastric or gastroesophageal junction adenocarcinoma) whose tumors overexpress the HER2 gene (HER2+).
Coalition group calls for bigger FDA budget
The Los Angeles Times reports that when the president's budget was announced, calling for an increase in the FDA's budget, "a coalition of public interest advocates, patient groups and healthcare industry interests regulated by the FDA had a swift response: It's not enough. 'We are disappointed in the president's budget request and ... will seek to increase' the budget, said Steven Grossman, deputy executive director of Alliance for a Stronger FDA.
Read more News
› Verified 1 days ago